Ab Index-Nr. 607-513-00-4

Index-Nr.Internationale chemische BezeichnungEG-Nr.CAS-Nr.EinstufungKennzeichnungbis 30.11.2018: Spezifische Konzentrations-
grenzen,
M-Faktoren
ab 01.12.2018: Spezifische Konzentrations-
grenzen
M-Faktoren und ATE
Anmer-
kungen
Gefahrenklasse, Gefahren-
kategorie und Gefahren-
kodierung
Kodierung der Gefahrenhin-
weise
Piktogramm, Kodierung der SignalworteKodierung der Gefahrenhin-
weise
Kodierung der ergänzenden Gefahren-
merkmale
607-513-00-4reaction mass of: trisodium 4-benzoylamino-6-(6-ethene­sulfonyl-1-sulfato-naphtha­len-2-ylazo)-5-hydroxy­naphthalene-2,7-disulfonate;
5-(benzoylamino)-4-hydro­xy-3-((1-sulfo-6-((2-(sul­fooxy)ethyl)sulfonyl)-2-naph­thyl)azo)naphthalene-2,7-disulfo­nic acid sodium salt;
5-(benzoylamino)-4-hydro­xy-3-((1-sulfo-6-((2-(sul­fooxy)ethyl)sulfonyl)-2-naph­thyl)azo)naphthalene-2,7-disul­fonic acid
423-200-3Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
   
607-514-00-Xpotassium N-(1-methoxy-1-oxo­but-2-en-3-yl)valinate427-240-2134841-35-3Skin Sens. 1H317GHS07
Wng
H317   
607-515-00-5reaction mass of: disodium hexyldiphenyl ether disulphonate;
disodium dihexyldiphenyl ether disulphonate
429-650-7147732-60-3Eye Irrit. 2
Aquatic Chronic 2
H319
H411
GHS07
GHS09
Wng
H319
H411
   
607-516-00-0N,N'-bis(trifluoroacetyl)-S,S'-bis-L-homocysteine429-670-6105996-54-1Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
   
607-517-00-6(S)-α-(acetylthio)benzenepropanoic acid430-300-076932-17-7Acute Tox. 4 (*)
Eye Dam. 1
Skin Sens. 1
H302
H318
H317
GHS05
GHS07
Dgr
H302
H318
H317
   
607-518-00-13-oxoandrost-4-ene-17-β-carboxylic acid414-990-0302-97-6Repr. 2
Aquatic Chronic 4
H361f
H413
GHS08
Wng
H361f
H413
   
607-519-00-7poly-[((4-((4-ethylethylene)a­mino)phenyl)-((4-(ethyl-(2-oxy­ethylene)amino)phenyl)me­thinyl)cyclohexa-2,5-dienyli­dene)-N-ethyl-N-(2-hydroxy­ethyl)ammonium acetate]427-280-0176429-27-9STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H335
H315
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H335
H315
H318
H410
   
607-520-00-2reaction mass of: sodium 4,5-
dihydro-2-[(propionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate;
disodium 4,5-dihydro-2-[(dipropio­nato)(C6-18)alkyl]-3H-imidazo­lium-N-ethylphosphate
427-740-0Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
   
607-521-00-8tetraethyl N,N´-(methylenedi­cyclohexane-4,1-diyl)bis-dl-aspartate429-270-1136210-30-5Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
607-522-00-3sodium salt of the polymer of:
sodium 2-methyl-buta-1,3-diene-1-sul­fonate with acrylic acid and 2-hydroxyethyl-2-methyl­acrylate
429-720-7184246-86-4Aquatic Chronic 3H412H412   
607-523-00-9reaction mass of mono to
tetra(lithium and/or sodium)3-amino-10-[4-(4-ami­no-3-sulfonatoanilino)-6-[me­vthyl-(2-sulfonatoethyl)ami­no]-1,3,5-triazin-2-ylami­no]-6-13-dichloroben­zo[1,2-B:4,5-B´]di[1,4]benzoxazi­ne-4,11-disulfonate; mono to tetra(lithium and/or sodium)3-ami­no-10-[4,6-bis(4-ami­no-3-sulfonato­ani­lino)-1,3,5-tria­zin-2-ylamino]-6-13-dichloroben­zo[1,2-B:4,5-B´]di[1,4]ben­zoxazine-4,11-disulfonate; mono to penta(lithium and/or sodium)10,10´-diami­no-6,6´,13,13´-tetrachlo­ro-3,3´-[6-[methyl-(2-sulfonato­ethyl)amino]-1,3,5-tria­zin-2,4-diyldiimino]bis[ben­zo[1,2-B:4,5-B´]di[1,4]benzoxa­zine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10-amino-6,6´,13,13´-tetra­chloro-10´[4-(4-amino-3-sulfonatoanilino)-[6-me­thyl-(2-sulfonatoethyl)ami­no]-1,3,5-triazin-2,4-diimino]bis[ben­zo[1,2-B:4,5-B´]di[1,4]benzoxa­zine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10,10´-diami­no-6,6´,3,3´[(2-sulfo­nato)-1,4-phenyl­enediimino­bis[6-methyl-(2-sulfonatoethyl)ami­no]-1,3,5-triazin-2,4-diyldiimi­no]bis[ben­zo[1,2-B:4,5-B´]di[1,4]benzoxa­zine-4,11-disulfonate
430-200-7Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
   
607-524-00-4tall oil 2-[(tetrahydro-2H-pyran-2-yl) thio]ethyl esters430-310-5Aquatic Chronic 4H413 H413   
607-525-00-X(Z)-2-methoxymino-2-[2-(tri­tylamino)thiazol-4-yl]acetic acid431-520-164485-90-1Flam. Sol. 1****
Carc. 2
Aquatic Chronic 3
H228
H351
H412
GHS02
GHS08
Dgr
H228
H351
H412
   
607-526-00-5cartap (ISO);
1,3-bis(carbamoylthio)-2-(di­methylamino)propane
15263-53-3Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
607-527-00-0reaction mass of: 1-(1'H,1'H,2'H,2'H-tridecafluo­rooctyl)-12-(1''H,1''H,2''H,2''H-tri­decafluorooctyl)dodecane­dioate;
1-(1'H,1'H,2'H,2'H-tridecafluo­rooctyl)-12-(1''H,1''H,2''H,2''H-
heptdecafluorodecyl)
dodecanedioate;
1-(1'H,1'H,2'H,2'H-tridecafluo­rooctyl)-12-(1''H,1''H,2''H,2''H-
heneicosafluorododecyl) dodecanedioate;
1-(1'H,1'H,2'H,2'H-tridecafluo­rooctyl)-12-(1''H,1''H,2''H,2''H-
pentacosafluorotetrade­cyl)do­decanedioate;
1-(1'H,1'H,2'H,2'H-heptadeca­fluorodecyl)-12-(1''H,1''H,2''H,2''H-hepta­decafluorode­cyl)dodecanedioate;
1-(1'H,1'H,2'H,2'H-heptadeca­fluorodecyl)-12-(1''H,1''H,2''H,2''H-heneico­safluorodode­cyl)dode­canedioate
423-180-6STOT RE 2 (*)H373 (*)(*)GHS08
Wng
H373 (*)(*)   
607-528-00-6(S)-3-methyl-2-(2-oxotetra­hydropyrimidine-1-yl)buty­ric acid430-900-2192725-50-1Eye Dam. 1H318GHS05
Dgr
H318   
607-529-00-1benzyl cis-4-ammonium-4´-
toluenesulfonato-
1-cyclohexanecarboxylate
426-070-667299-45-0Aquatic Chronic 3H412H412   
607-530-00-7reaction mass of isomers of: C7-9-alkyl 3-(3,5-di-tert-butyl-4-
hydroxyphenyl)propionate
406-040-9125643-61-0Aquatic Chronic 4H413H413   
607-531-00-2methyl 3-amino-4,6-dibromo-2-
methyl-benzoate
425-190-6119916-05-1STOT RE 2 *
Aquatic Chronic 2
H373 **
H411
GHS08
GHS09
Wng
H373 **
H411
   
607-532-00-8(S)-1-[2-tert-butoxycarbonyl-3-
(2-methoxyethoxy)propyl]-1-
cyclopentanecarboxylic acid,
cyclohexylamine salt
425-510-4167944-94-7Aquatic Chronic 3H412H412   
607-533-00-3pentasodium monohydrogen
6-chloro-3,10-bis[2-[4-chloro-6
(2,4-disulfophenylamino)-1,3,5-
triazin-2-yl-amino]ethylamino]-
13-ethylbenzo[5.6][1.4]oxazi­no[2,3-b]phenoxazine-4,11-
disulfonate
414-910-4Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
   
607-534-00-9ethyl 2-(3-benzoylphenyl)pro­panoate414-920-960658-04-0Acute Tox. 3 *
STOT RE 1
Skin Sens. 1
Aquatic Chronic 2
H301
H372 **
H317
H411
GHS06
GHS08
GHS09
Dgr
H301
H372 **
H317
H411
   
607-535-00-4potassium 4-iodo-2-sulfonato-
benzoic acid
426-620-5Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
   
607-536-00-X(2,6-xylyloxy) acetic acid430-910-713335-71-2Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
   
607-537-00-5isopropylammonium
2-(3-benzoylphenyl)propionate
417-970-1Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 1
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H312
H372 **
H318
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H301
H312
H372 **
H318
H410
   
607-539-00-6propyl((4-(5-oxo-3-
propylisoxazolidin-4-yliden­methin)phenyl)propoxycar­bonylmethyleneamino)acetate
431-000-2198705-81-6Aquatic Chronic 4H413H413   
607-540-00-11-(mercaptomethyl)cyclopro­pylacetic acid420-240-3162515-68-6Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H314
H312
H302
H317
H411
GHS05
GHS07
GHS09
Dgr
H314
H312
H302
H317
H411
   
607-541-00-7[(1-methyl-1,2-ethanediyl)
bis[nitrilobis(methylene)]]tetraki-
s(phosphonic acid)
421-940-128698-31-9Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
   
607-542-00-2methyl 2-(4-butanesulfon­amidophenoxy)tetradecanoate422-110-1Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
607-543-00-8poly-[((4-((4-(ethyl-ethyle­ne)amino)phenyl)-(4-(ethyl-(2-
oxyethylene)amino)phen­yl)methinyl)-3-methylcyclo­hexa-2,5-dienylidene)-N-ethyl-N-
(2-hydroxyethyl)ammonium acetate]
427-480-8176429-22-4STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H335
H315
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H335
H315
H318
H410
   
607-544-00-3ethyl 6,8-difluoro-1-(formyl­methylamino)-1,4-dihydro-7-
(4-methyl)piperazin-1-yl)-4-oxo-
quinoline-3-carboxylate
427-490-2158585-86-5Aquatic Chronic 3H412H412   
607-545-00-91,2-dimethyl-3-(1-
methylethenyl)cyclopentyl acetate
424-070-094346-09-5Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
   
607-546-00-4reaction mass of: methyl
{[5-acetylamino-4-(2-chloro-4-
nitrophenylazo)phenyl]
methoxycarbonylmethylamino}
acetate;
methyl {[5-acetylamino-4-(2-
chloro-4-nitrophenylazo)phen­yl]ethoxycarbonylmethylami­no}acetate
424-290-7188070-47-5Skin Sens. 1H317GHS07
Wng
H317   
607-547-00-X18-methylnonadecyl
2,2-dimethylpropanoate
424-370-1125496-22-2Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4
H315
H317
H413
GHS07
Wng
H315
H317
H413
   
607-548-00-51-(2,4-dichlorophenyl)-2-(1H-
imidazol-1-yl)ethanone methanesulfonate
431-010-7154486-26-7Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
   
607-549-00-0methyl (E)-2((3-(1,3-benzo­dioxol-5-yl)-2-methyl-1-prope­nyl)amino)benzoate424-430-7125778-19-0Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
607-550-00-62-amino-4-bromo-5-chloro­benzoic acid424-700-4Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
   
607-551-00-1tetrabutylammonium 2-amino-6-
iodopurinate
424-710-9156126-48-6Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H312
H302
H373 **
H315
H318
H317
H411
GHS05
GHS08
GHS07
GHS09
Dgr
H312
H302
H373 **
H315
H318
H317
H411
   
607-552-00-7hexadecyl 3-amino-4-
isopropoxybenzoate
424-830-1Aquatic Chronic 4H413H413   
607-553-00-27-amino-4-hydroxy-2-
naphthalenesulfonic acid, coupled with 5 (or 8) -amino-8
(or 5)-[[4-[[4-[[4-amino-6(or 7)-sulfo-1-naphthyl]azo]phenyl]
amino]-3-sulfophenyl]azo]-2-
naphthalenesulfonic acid and
4-hydroxy-7-(phenylamino)-2-
naphthalenesulfonic acid, sodium salt
424-850-0Eye Dam. 1H318GHS05
Dgr
H318   
607-554-00-82,4-diamino-5-[4-[(2-sulfoxyl ethyl)sulfonyl]phenylazo]ben­zenesulfonic acid424-870-127624-67-5Expl. 1.1
Eye Dam. 1
Aquatic Chronic 3
H201
H318
H412
GHS01
GHS05
Dgr
H201
H318
H412
   
607-555-00-31,1,3,3-tetramethylbutyl­per­oxypivalate424-980-822288-41-1Flam. Liq. 2
Org. Perox. D
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H225
H242
H315
H317
H411
GHS02
GHS07
GHS09
Dgr
H225
H242
H315
H317
H411
   
607-556-00-92-acetoxymethylene-4-
acetylphenylacetate
425-160-224085-06-1Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 **
H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H302
H373 **
H318
H317
H410
   
607-557-00-4salt of: (1S-cis)-1-amino-2,3-di­hydro-1H-inden-2-ol and [R-[R*R*]]-2,3-dihydroxy­butanedioic acid425-210-3169939-84-8Skin Sens. 1H317GHS07
Wng
H317   
607-558-00-X2S-isopropyl-5R-methyl-1R-
cyclohexyl (2R,5S)-5-(4-amino-
2-oxo-2H-pyrimidin-1-yl)-[1,3]-
oxathiolane-2-carboxylate
425-250-1147027-10-9Aquatic Chronic 2H411GHS09H411   
607-559-00-5coconut oil, reaction products with glycerol esters of 3,5-bis(1,1-dimethylethyl)-4-
hydroxybenzenepropanoic acid
425-400-6179986-09-5Aquatic Chronic 4H413H413   
607-560-00-0(R,S)-2-butyloctanedioic acid431-210-450905-10-7Eye Dam. 1H318GHS05
Dgr
H318   
607-561-00-6sodium 4-hydroxy-3-(N´-(2-
(2-hydroxyethylenesulfonyl)
ethylene)ureido)-5-
nitrobenzenesulfonate
425-460-3Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
607-562-00-1reaction mass of: (2R,3R)-3-
(2-ethoxyphenoxy)-2-hydroxy-
3-phenylpropylammonium methanesulfonate;
(2S,3S)-3-(2-ethoxyphenoxy)-
2-hydroxy-3-phenylpro­pylam­monium methane­sulfo­nate
425-530-398769-75-6Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
   
607-563-00-75,7-dichloro-4-hydroxyquino­line-3-carboxylic acid431-250-2171850-30-9Aquatic Chronic 2H411GHS09H411   
607-564-00-21,6-hexanediammonium, sodium 5-sulfato-1,3-ben­zene­dicar­boxylate425-730-051178-75-7Skin Sens. 1H317GHS07
Wng
H317   
607-565-00-83-ethyl 5-methyl
2-(2-aminoethoxymethyl)-4-
(2-chlorophenyl)-1,4-dihydro-6-
methyl-3,5-pyridine­dicarboxy­late
425-820-188150-42-9Acute Tox. 3 *
STOT RE 2 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H373 **
H318
H400
H410
GHS06
GHS05
GHS08
GHS09
Dgr
H301
H373 **
H318
H410
   
607-566-00-3reaction mass of: dodecyl­phenyl dodecyl­hydroxy­benzenecar­boxylate;
bis(dodecylphenyl)dodecyl hydroxybenzenedi­carboxy­late
426-140-6Aquatic Chronic 4H413H413   
607-567-00-9potassium 3-iodo-6-
methylbenzenesulfonate
426-300-5Eye Dam. 1H318GHS05
Dgr
H318   
607-568-00-4potassium 2-chloro-3-
(benzyloxy)propionate
426-350-8138666-92-9Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
H302
H373 **
H318
H317
GHS05
GHS08
GHS07
Dgr
H302
H373 **
H318
H317
   
607-569-00-Xreaction mass of: sodium
2-amino-4-(2,6-difluoropyrim-
idin-4-ylamino)benzene-
sulfonate;
sodium 2-amino-4-(4,6-
difluoropyrimidin-4-
ylamino)benzenesulfonate
426-470-0Skin Sens. 1H317GHS07
Wng
H317   
607-570-00-5sodium (6R-trans)-7-amino-8-oxo-3-
[[[1-(sulfomethyl)-1H-
tetrazol-5-yl]
thio]methyl]-5-thia-1-azabicyclo
[4.2.0]oct-2-ene-2-carboxylate
monohydrate
426-520-171420-85-4Skin Sens. 1H317GHS07
Wng
H317   
607-571-00-02-cyclopentene-1-acetic acid,
3-hydroxy-2-pentyl-, methyl ester acetate
431-400-757374-49-9Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
607-572-00-6diethyl thiophosphoryl (Z)-(2-
aminothiazol-4-yl)methoxyi­mino acetate
426-790-0162208-27-7Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H373 **
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H312
H302
H373 **
H317
H410
   
607-573-00-1reaction mass of: disodium 7-(2,4-difluoropyrimidin-6-yla­mino)-4-hydroxy-3-(4-metho­xy-2-sulfonatophenylazo)naph­thalene-2-sulfonate;
disodium 7-(4,6-difluoro­pyrimidin-2-yla­mino)-4-hydroxy-3-(4-
methoxy-2-sulfonato­phenylazo)naphtha­lene-2-sulfonate
426-840-1Eye Dam. 1H318GHS05
Dgr
H318   
607-574-00-7[1R-(1-α,2β,5α)]-mono[5-
methyl-2-(1-methylethyl)cy-
clohexyl]butanedioate
426-890-477341-67-4Eye Dam. 1H318GHS05
Dgr
H318   
607-575-00-24-(5-(5-[1-(4-carboxy­phenyl)hexahydro-2,4,6-
trioxopyrimidin-5-ylidene]pen­ta-1,3-dienyl)-1,2,3,4-tetrahy­dro-6-hydroxy-2,4-dioxopyri­midin-1-yl)benzoic acid-triethylamine salt
426-900-7STOT SE 3
Aquatic Chronic 3
H335
H412
GHS07
Wng
H335
H412
   
607-576-00-8branched, octyl 3-[3,5-di(tert-­butyl)-4-hydroxy­phe­nyl]pro­panoate427-030-0Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
607-577-00-3(2R*,3S*)-2-(2,4-difluoro­phe­nyl)-3-(5-fluoro-4-pyrimi­dinyl)-1-(1H-1,2,4-tria­zol-1-yl)bu­tan-2-ol(1R)-10-camphor­sulfo­nate427-100-0Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H318
H317
H412
GHS05
GHS07
Dgr
H302
H318
H317
H412
   
607-578-00-9ethyl 4-((4-diethylamino-2-
methylphenyl)imino)-4,5-di­hydro-1-isopropyl-5-oxo-1H-py­razole-3-carboxylate
427-110-5Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 4
H302
H373 **
H413
GHS08
GHS07
Wng
H302
H373 **
H413
   
607-579-00-4diethyl[(p-ethoxyanilino)me­thylene]malonate431-430-0103976-28-9Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
   
607-580-00-Xethyl 7-chloro-1-(2,4-
difluorophenyl)-6-
fluoro-1,4-dihydro-4-oxo-1,8-
naphthyridine-3-carboxylate
422-360-1100491-29-0Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
607-581-00-5ethyl 2-ethoxy-4-
carboxymethylbenzoate
427-630-299469-99-5Eye Dam. 1H318GHS05
Dgr
H318   
607-582-00-0reaction mass of: tetrasodium
7-(4-(4-fluoro-6-(4-(2-
sulfonatoethylsulfonyl)phenyl­amino)-1,3,5-triazin-2-ylami­no)-2-ureidophenylazo)naph­thalene-1,3,6-trisulfonate;
tetrasodium 7-(4-(4-hy­droxy-6-(4-(2-sul­fonatoethylsulfonyl)phe­nylami­no)-1,3,5-triazin-2-yl­amino)-2-ureidophenyl­azo)naph­thalene-1,3,6-tri­sulfonate
427-650-1Aquatic Chronic 3H412H412   
607-583-00-64-amino-3-[[4-[[2-(sulfo­oxy)ethyl]sulfonyl]phenyl]azo]-
1-naphthalene sulfonic acid
427-680-5188907-52-0Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
   
607-584-00-1trisodium 3-[2-acetylamino-4-
[4-chloro-6-[4-(2-
sulfonatoxyethylsulfonyl)
phenylamino]-1,3,5-triazine-2-
ylamino]phenylazo]naphtha­lene-1,5-disulfonate
427-710-7215612-56-9Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
   
607-585-00-7strontium
2-[(2-hydroxy-6-sulfonato-1-
naphthyl)azo]naphthalene-1-
sulfonate
427-930-3Skin Sens. 1H317GHS07
Wng
H317   
607-586-00-2dodecyl 3-amino-4-chlorobenzoate428-020-96195-20-6Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
   
607-587-00-8ethyl cis-4-[4-[[2-(2,4-
dichlorophenyl)-2-(1H-imidazol-
1-ylmethyl)-1,3-dioxolan-4-
yl]methoxy]phenyl]piperazine-1-
carboxylate
428-030-367914-69-6Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 **
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373 **
H410
   
607-588-00-3reaction mass of: 2-ethylhexyl
2,3,4,5-tetrabromobenzoate;
bis(2-ethylhexyl) 3,4,5,6-
tetrabromophthalate
428-050-2Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
   
607-589-00-9tetrakis(1,2,2,6,6-pentamethyl-
4-piperidyl)-1,2,3,4-
butanetetracarboxylate
428-070-191788-83-9STOT RE 1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H372 **
H302
H400
H410
GHS08
GHS07
GHS09
Dgr
H372 **
H302
H410
   
607-590-00-4hexadecyl 3-[2-(5,5-dimethyl-
2,4-dioxo-1,3-oxazolidin-3-yl)-
4,4-dimethyl-3-oxovaleramido]-
4-isopropoxybenzoate
428-140-1210706-50-6Aquatic Chronic 4H413H413   
607-591-00-Xreaction mass of: trisodium 5-(4-fluoro-6-morpholin-4-yl-
1,3,5-triazin-2-ylamino)-4-
hydroxy-3-(4-(2-sulfooxy-
ethanesulfonyl)
phenylazo)naphthalene-2,7-
disulfonate;
disodium 3-(4-ethenesulfonyl-
phenylazo)-5-(4-fluoro-6-
morpholin-4-yl-1,3,5-
triazin-2-ylamino)-4-
hydroxynaphthalene-2,7-
disulfonate
428-400-4Eye Dam. 1H318GHS05
Dgr
H318   
607-592-00-5di(C9-11-alkyl) cyclohexane-
1,4-dicarboxylate
428-870-0Aquatic Chronic 4H413H413   
607-593-00-04-(2-methylacryloyloxy)phenyl
4-allyloxybenzoate
429-000-2159235-16-2Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
607-594-00-6ethyl (1S,5R,6S)-5-(1-
ethylpropoxy)-7-oxabi­cyclo[4.1.0]hept-3-ene-3-carboxy­late
429-020-1204254-96-6STOT RE 2 *
Skin Sens. 1
H373 **
H317
GHS08
GHS07
Wng
H373 **
H317
   
607-595-00-1N-amidino-N-methylglycine-2-
oxopropionate
429-120-5208535-04-0Eye Dam. 1H318GHS05
Dgr
H318   
607-596-00-7ethyl 2-(4-phenoxy­phenyl)lactate429-220-9132584-17-9Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
   
607-597-00-2tetrasodium 4,4´-bis{4-[4-(2-
hydroxyethylamino)-
6-(4-sulfonatoanilino)-1,3,5-
triazin-2-ylamino]phenyla­zo}stilbene-2,2´-disulfonate
429-230-3Eye Dam. 1H318GHS05
Dgr
H318   
607-598-00-8trisodium 3-amino-4-[4-[4-(2-(2-
ethenylsulfonylethoxy)ethyla­mino)-6-fluoro-1,3,5-triazine-2-
ylamino]-2-sulfophenylazo]-5-
hydroxynaphthalene-2,7-disul­fonate
429-240-8212652-59-0Eye Dam. 1H318GHS05
Dgr
H318   
607-599-00-31,1-dimethylpropyl
3,5,5-trimethylperoxyhexa­noate
431-610-968860-54-8Org. Perox. D
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H242
H317
H400
H410
GHS02
GHS07
GHS09
Dgr
H242
H317
H410
   
607-600-00-7(1S,1´R)-[1-(3´,3´-dimethyl-1´-
cyclohexyl)ethoxycarbonyl]methyl propanoate
431-700-8Aquatic Chronic 2H411GHS09H411   
607-601-00-21,4-dihydroxy-2,2,6,6-tetra­methyl piperidinium-2-hy­droxy-1,2,3-propanetricar­boxylate429-370-5220410-74-2Acute Tox. 4 *H302GHS07
Wng
H302   
607-602-00-8ethyl (3-cyanomethyl-
3,4-dihydro-4-oxophtha­lazin-1-yl)acetate
429-680-0122665-86-5Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
607-603-00-3lithium sodium 4,4´,4´´-
(nitrilotris(ethane-2,1-diylimino
(6-chloro-1,3,5-triazine-4,2-
diyl)imino))tris(5-hydroxy-6-(1-
sulfonaphthalene-2-ylazo)-2,7-
naphthalene)disulfonate
429-730-1193562-37-7Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
   
607-604-00-9guanidinium benzoate429-820-026739-54-8Acute Tox. 4 *H302GHS07
Wng
H302   
607-605-00-4methyl 4-iodo-2-(3-(4-
methoxy-6-methyl-1,3,5-
triazine-2-yl)ureidosulfo­nyl)benzoate
429-890-2144550-06-1Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
607-606-00-X(Z)-2-(2-t-butoxycarbonyl­amino-4-thiazolyl)pent-2-
enoic acid
430-100-386978-24-7Acute Tox. 4 *H302GHS07
Wng
H302   
607-607-00-5reaction mass of: calcium bis(C10-14 branched alkyl salicylate);
calcium bis(C18-30-alkyl salicylate);
calcium C10-14 branched alkylsalicylato-C18-30-alkyl salicylate;
calcium bis (C10-14 branched alkyl phenolate);
calcium bis (C18-30-alkyl phenolate);
calcium C10-14 branched alkylphenolato-C18-30-alkyl phenolate;
C10-14 branched alkyl phenol;
C18-30-alkyl phenol
430-180-1Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
   
607-608-00-0pentapotassium 2-(4-{5-[1-(2,5-
disulfophenyl)-4,5-dihydro-3-
methylcarbamoyl-5-
oxopyrazol-4-ylidene]-3-(2-
pyrrolidinone-1-yl)-1,3-
pentadienyl}-3-methylcarba­moyl-5-oxopyrazol-1-yl)ben­zene-1,4-disulfonate
430-210-1Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
607-609-00-6ethyl (3R)-4-cyano-3-
hydroxybutanoate
430-220-6141942-85-0Eye Irrit. 2H319GHS07
Wng
H319   
607-610-00-1trisodium 4-hydroxy-6-
(sulfonatomethylamino)-5-(2-(2-
sulfatoethylsulfonyl)
phenylazo)naphthalene-2-
sulfonate
430-280-3Skin Sens. 1H317GHS07
Wng
H317   
607-611-00-7methyl 3-amino-2,2,3-
trimethylbutyrate
431-720-790886-53-6Skin Corr. 1B
Acute Tox. 4 *
Aquatic Chronic 3
H314
H302
H412
GHS05
GHS07
Dgr
H314
H302
H412
   
607-612-00-2reaction mass of:
3,3,4,4,5,5,6,6,7,7,8,8,8-
tridecafluoro-1-octanesulfonic acid;
ammonium 3,3,4,4,5,5,6,6,7,7,8,8,8-
tridecafluoro-1-octanesulfonate
432-190-1182176-52-9Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
H302
H373 **
H318
GHS05
GHS08
GHS07
Dgr
H302
H373 **
H318
   
607-613-00-8reaction mass of:
succinic acid
monopersuccinic acid
dipersuccinic acid
monomethyl ester of succinic acid
monomethyl ester of persuccinic acid
dimethyl succinate glutaric acid
monoperglutaric acid
diperglutaric acid
monomethyl ester of glutaric acid
monomethyl ester of perglutaric acid
dimethyl glutarate adipic acid
monoperadipic acid
diperadipic acid
monomethyl ester of adipic acid
monomethyl ester of peradipic acid
dimethyl adipate
hydrogen peroxide
methanol
water
432-790-1 Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
STOT SE 2
H332
H312
H302
H314
H371 (Augen)
GHS07
GHS05
GHS08
Dgr
H332
H312
H302
H314
H371 (Augen)
   
607-614-00-32-(10-oxo-10H-9-oxa-10-
phosphaphenanthren-10-
ylmethyl)succinic acid
426-480-563562-33-4Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
607-615-00-9reaction product of thioglycerol and mercaptoacetic acid consisting mainly of 3-mercapto-1,2-bismercap­toacetoxypropane and oligomers of this substance431-120-5Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
H331
H302
H319
H317
GHS06
Dgr
H331
H302
H319
H317
   
607-616-00-42,4-dichloro-5-fluorobenzoyl­chloride428-390-186393-34-2STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H335
H315
H318
H317
H412
GHS05
GHS07
Dgr
H335
H315
H318
H317
H412
   
607-617-00-Xbis(2-ethylhexyl)-4,5-
epoxycyclohexane-1,2-dicar­boxylate
430-700-510138-36-0Skin Sens. 1H317GHS07
Wng
H317   
607-618-00-5menadione sodium bisulfite;
2-naphthalenesulfonic acid, 1,2,3,4-tetrahydro-2-methyl-
1,4-dioxo-, sodium salt
204-987-0130-37-0Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H315
H400
H410
GHS07
GHS09
Wng
H319
H315
H410
   
607-619-00-0menadione nicotinamide bisulfite;
1,2,3,4-tetrahydro-2-methyl-1,4-
dioxonaphthalene-2-sulfonic acid,
compound with nicotin-3-amide (1:1)
277-543-773581-79-0Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H315
H400
H410
GHS07
GHS09
Wng
H319
H315
H410
   
607-620-00-6trisodium nitrilotriacetate225-768-65064-31-3Carc. 2
Acute Tox. 4 *
Eye Irrit. 2
H351
H302
H319
GHS08
GHS07
Wng
H351
H302
H319
 Carc. 2; H351:
C ≥ 5 %
 
607-621-00-1milbemectin (ISO);
[reaction mass of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)]
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H400
H410
GHS07
GHS09
Wng
H332
H302
H410
 M = 100 
607-622-00-72-ethylhexyl-2-ethylhexanoate231-057-17425-14-1Repr. 2H361d ***GHS08
Wng
H361d ***   
bis 28.02.2018
607-623-00-2
diisobutyl phthalate201-553-284-69-5Repr. 1BH360DfGHS08
Dgr
H360Df Repr. 1B; H360Df:
C ≥ 25 %
Repr. 2; H361f: 5 % ≤ C < 25 %
 
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
607-623-00-2
Diisobutylphthalat201-553-284-69-5Repr. 1BH360DfGHS08
Dgr
H360Df   
607-624-00-8perfluorooctane sulfonic acid;
heptadecafluorooctane-1-
sulfonic acid; [1]
potassium perfluorooctanesulfonate;
potassium heptadecafluorooctane-1-
sulfonate; [2]
diethanolamine perfluorooctane sulfonate; [3]
ammonium perfluorooctane sulfonate;
ammonium heptadecafluorooctane-
sulfonate; [4]
lithium perfluorooctane sulfonate;
lithium heptadecafluorooc­tanesulfonate [5]
217-179-8 [1]
220-527-1 [2]
274-460-8 [3]
249-415-0 [4]
249-644-6 [5]
1763-23-1 [1]
2795-39-3 [2]
70225-14-8 [3]
29081-56-9 [4]
29457-72-5 [5]
Carc. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Lact.
Aquatic Chronic 2
H351
H360D ***
H372 **
H332
H302
H362
H411
GHS08
GHS07
GHS09
Dgr
H351
H360D ***
H372 **
H332
H302
H362
H411
   
607-625-00-3clodinafop-propargyl (ISO)105512-06-9Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 **
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H302
H373 **
H317
H410
 Skin Sens. 1; H317:
C ≥ 0,001 %
M = 1
 
607-626-00-9ethyl 1-(2,4-dichlorophenyl)-5-
(trichloromethyl)-1H-1,2,4-
triazole-3-carboxylate
401-290-5103112-35-2Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H400
H410
GHS08
GHS09
Dgr
H350
H410
   
607-627-00-4[(4S,5S)-4-benzyl-2-oxo-5-
oxazolidinyl]methyl
4-nitrobenzenesulfonate
416-360-0162221-28-5Skin Sens. 1H317GHS07
Wng
H317   
607-628-00-X4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine419-240-6171054-89-0Eye Dam. 1H318GHS05
Dgr
H318   
607-629-00-5[[2-methyl-1-(1-
oxopropoxy)propoxy](4-
phenylbutyl)phosphinyl] acetic acid
419-270-1123599-82-6Eye Irrit. 2H319GHS07
Wng
H319   
607-630-00-0acrylic acid, 3-(trimethoxysilyl)propyl ester419-560-64369-14-6Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3
H332
H314
H317
H412
GHS05
GHS07
Dgr
H332
H314
H317
H412
   
607-631-00-6reaction mass of: 2-(2-
((oxo(phenyl)acetyl)oxy)etho­xy)ethyl oxo(phenyl)acetate;
(2-(2-hydroxyethoxy)ethyl)
oxo(phenyl)acetate
442-300-8Skin Sens. 1H317GHS07
Wng
H317   
607-632-00-1N-[3-(2,4-di-(1,1-dimethyl-
propyl)phenoxy)-propyl]-1-
hydroxy-5-(2-methylpropyl-
oxycarbonylamino)-
naphthamide
420-210-1111244-14-5Aquatic Chronic 4H413H413   
607-633-00-7trisodium 5-{[4-chloro-6-(1-
naphthylamino)-1,3,5-triazin-2-
yl]amino}-4-hydroxy-3-[(E)-(4-
methoxy-2-
sulfonatophenyl)diazenyl]-2,7-
naphthalenedisulfonate
440-480-2341026-59-3Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
   
607-634-00-2(S)-(–)-2-acetoxypropionylchloride;
(1S)-2-chloro-1-methyl-2-
oxoethyl acetate
420-610-436394-75-9Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
H302
H314
H317
GHS05
GHS07
Dgr
H302
H314
H317
   
607-635-00-8trisodium N-(3-propionato)-l-
aspartate
422-090-4172737-80-3Eye Dam. 1H318GHS05
Dgr
H318   
607-636-00-31-bromo-2-methylpropyl propionate422-900-6158894-67-8Flam. Liq. 3
Carc. 2
Skin Corr. 1B
Skin Sens. 1
H226
H351
H314
H317
GHS02
GHS05
GHS08
GHS07
Dgr
H226
H351
H314
H317
   
607-637-00-9disodium 8-amino-5-{4-[2-
(sulfonatoethoxy)sulfonyl]phe­nylazo}naphthalene-2-sulfonate
423-730-5250688-43-8Eye Dam. 1H318GHS05
Dgr
H318   
607-638-00-42-hydroxybenzoic acid 2-butyloctyl ester431-090-3190085-41-7Aquatic Chronic 4H413H413   
607-639-00-X2-(2-oxo-5-(1,1,3,3-
tetramethylbutyl)-2,3-dihydro-1-
benzofuran-3-yl)-4-(1,1,3,3-
tetramethylbutyl)phenyl acetate
431-770-1216698-07-6Aquatic Chronic 4H413H413   
607-641-00-02-(formylamino)-3-
thiophenecarboxylic acid;
2-formamido-3-thiophene­carboxylic acid
431-930-943028-69-9Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317
   
607-642-00-63,6,9-trithiaundecamethylene-
1,11-dimethacrylate
432-210-7141631-22-3Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
607-643-00-1dimethyl (2S)-2-hydroxysuccinate432-310-0617-55-0Flam. Liq. 3
Eye Dam. 1
Skin Sens. 1
H226
H318
H317
GHS02
GHS05
GHS07
Dgr
H226
H318
H317
   
607-644-00-7methyl 2,2-dimethyl-6-
methylenecyclohexane­carboxylate
432-350-981752-87-6Skin Irrit. 2H315GHS07
Wng
H315   
607-645-00-2tetrasodium 2-(4-fluoro-6-(methyl-
(2-(sulfatoethylsulfonyl)
ethyl)amino)-1,3,5-triazin-2-
ylamino)-5-hydroxy-6-(4-methyl-
2-sulfonatophenylazo)
naphthalene-1,7-disulfonate
432-550-6243858-01-7Eye Dam. 1H318GHS05
Dgr
H318   
607-646-00-8d-erythro-hexanoic acid
2,4-dideoxy-3,5-O-(1-
methylethylidene)-1,1-
dimethylethylester;
tert-butyl 2-[(4R,6S)-6-
(hydroxymethyl)-2,2-dimethyl-
1,3-dioxan-4-yl]acetate
432-960-5124655-09-0Acute Tox. 4 *H302GHS07
Wng
H302   
607-647-00-35-acetoxy-2-(R,S)butyryloxy­methyl-1,3-oxathiolane433-530-1143446-73-5Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
H302
H317
H400
GHS07
GHS09
Wng
H302
H317
H400
   
607-649-00-4[3-(chlorocarbonyl)-2-
methylphenyl]acetate
433-690-0167678-46-8Skin Corr. 1A
Skin Sens. 1
H314
H317
GHS05
GHS07
Dgr
H314
H317
   
607-650-00-X2-methyl-1,5-pentanediamine-
1,3-benzenedicarboxylate
433-910-5145153-52-2Skin Sens. 1H317GHS07
Wng
H317   
607-651-00-5sodium 2-(nonanoyloxy)ben­zenesulfonate434-360-991125-43-8Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
   
607-652-00-0ethyl N2-dodecanoyl-l-
argininate hydrochloride
434-630-660372-77-2Eye Dam. 1
Aquatic Acute 1
H318
H400
GHS05
GHS09
Dgr
H318
H400
   
607-653-00-6tetrakis(bis(2-hydroxyethyl)
methylammonium)
3-(4-(7-acetylamino-1-hydroxy-
3-sulfonatonaphthalen-2-
ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-
sulfonato­phenylamino)-
4-hydroxy­naphthalene-
2-sulfonate
434-840-8225786-91-4Aquatic Chronic 2H411GHS09H411   
607-654-00-1(S)-3-hydroxy-γ-
butyrolactone
434-990-47331-52-4Skin Sens. 1H317GHS07
Wng
H317   
607-655-00-7ethyl 6,8-dichlorooctanoate435-080-11070-64-0Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
607-656-00-2sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-
[(2-methyl-4-sulfophenyl)amino]-
1,3,5-triazin-2-yl]amino]-2-
sulfophenyl]azo]-5-hydroxy-2,7-
naphthalenedisulfonic acid
435-350-7141250-43-3Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
   
607-657-00-8pentasodium 7-(4-(4-(3-(2-
sulfatoethanesulfonyl)phe­nylamino)-6-(4-(2-sulfato­ethanesulfonyl)phenylamino)-
1,3,5-triazin-2-ylamino)-2-
ureidophenylazo)naphthalene-
1,3,6-trisulfonate
436-920-8172399-10-9Eye Dam. 1H318GHS05
Dgr
H318   
607-658-00-33,10-diamino-6,13-dichloro-2-
((6-(((4-(1,1-dimethylethyl)phe-
nyl)sulfonyl)amino)-
2-naphthalenyl)sulfonyl)-4,11-
triphenodioxazinedisulfonic acid, lithium potassium sodium salt
440-770-9371921-63-0Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
   
607-659-00-9pentasodium N-[5-[[4-[[3-
[(aminocarbonyl)amino]-4-
[(3,6,8-trisulfonatonaphthalen-2-
yl)azo]phenyl]amino]-6-chloro-
1,3,5-triazin-2-yl]amino]-2-
sulfonato-4-[[4-[[-2-
(oxysulfonato)ethyl]
sulfonyl]phenyl]azo]phenyl]-3-
aminopropanoic acid
442-030-0321912-47-4Eye Dam. 1H318GHS05
Dgr
H318   
607-660-00-42-{4-[4-[4-fluoro-6-(2-
(2-vinylsulfonylethoxy)ethyl­amino)-1,3,5-triazin-2-ylamino]
phenylazo]phenylazo}naphthalene-4,6,8-trisulfonate, trisodium salt
442-230-8321679-52-1Eye Dam. 1H318GHS05
Dgr
H318   
607-661-00-X1,1-dimethylethyl
4´-(bromomethyl)biphenyl-2-
carboxylate
442-850-9114772-40-6Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
   
607-662-00-5methyl 2-(acetylamino)-3-
chloropropionate
442-860-387333-22-0Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
   
607-663-00-0bis(2-ethylhexyl) naphthalene-2,6-
dicarboxylate
442-980-6127474-91-3Aquatic Chronic 4H413H413   
607-664-00-6methyl 2-chlorosulfonyl-4-
(methanesulfonylaminomethyl)
benzoate
443-120-2393509-79-0Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
   
607-665-00-1trans-methyl-2-ethyl-but-2-
enoate
443-150-6101226-85-1Flam. Liq. 3H226GHS02
Wng
H226   
607-666-00-7(2S)-5-(benzyloxy)-2-(1,3-
dioxo-1,3-dihydro-2H-isoindol-
2-yl)-5-oxopentanoic acid
443-560-588784-33-2Eye Irrit. 2H319GHS07
Wng
H319   
607-667-00-2chloro-1-ethylcyclohexyl carbonate444-950-899464-83-2Muta. 2
Skin Sens. 1
H341
H317
GHS08
GHS07
Wng
H341
H317
   
607-668-00-8trans-2-isopropyl-5-carboxy-1,3-
dioxane
445-770-242031-28-7Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
   
607-669-00-3methyl (9-acetoxy-
3,8,10-triethyl-7,8,10-trimethyl-
1,5-dioxa-9-aza-spiro[5.5]un­dec-3-yl)octadecanoate
445-990-9376588-17-9Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
   
607-670-00-9dibutyl-3-(4-(5-ammonio-2-
butyl)benzofuran-3-
yl)carbonyl)phenoxy)propyl
ammonium oxalate;
(5-amino-2-butylbenzofuran-3-
yl)[4-(3-dibutylaminopropo­xy)phenyl]methanone, dioxalate
448-700-9500791-70-8STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H373 **
H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H373 **
H318
H317
H410
 M = 10 
607-671-00-4diethyl 1,4-cyclohexane­dicarboxylate417-310-072903-27-6Aquatic Chronic 2H411GHS09H411   
607-672-00-Xreaction mass of: 2-hydroxy-3-
(methacryloyloxy)propyl
(2-benzoyl)benzoate;
1-hydroxymethyl-2-
(methacryloyloxy)ethyl
(2-benzoyl)benzoate;
x-hydroxy-y-
(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate
419-000-0Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
607-673-00-51-ethyl-5,6,7,8-tetrahydro­quinolinium tosylate419-570-0Acute Tox. 4 *
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
   
607-675-00-6reaction mass of: cis-9-
octadecenedioic acid;
cis-9-cis-12-octadecadienedioic acid;
hexadecanedioic acid;
octadecanedioic acid
422-260-8Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
   
607-676-00-1reaction mass of:
2-methylnonanedioic acid;
2,4-dimethyl-4-methoxy­carbonylundecanedioic acid;
2,4,6-trimethyl-4,6-dimethoxy­carbonyltridecanedioic acid;
8,9-dimethyl-8,9-dimethoxy­carbonylhexadecanedioic acid
423-670-1Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
   
607-677-00-72,5-dioxopyrrolidin-1-yl
N-{[methyl[[2-(1-methylethyl)-4-
thiazolyl]methyl]amino]car­bonyl}-l-valinate
424-660-8STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
H373 **
H318
H317
GHS05
GHS08
GHS07
Dgr
H373 **
H318
H317
   
607-678-00-2reaction mass of: ethyl (2R,3R)-3-isopropylbi­cyclo[2.2.1]hept-5-ene-2-car­boxylate;
ethyl (2S,3S)-3-isopropyl­bicyclo[2.2.1]hept-5-ene-2-
carboxylate
427-090-8Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
607-679-00-8reaction mass of: 3-{5-[3-(4-{1,6-
dihydro-2-hydroxy-4-methyl-
1-[3-(methylammonio)propyl]-
6-oxo-3-pyridylazo}benzami-
do)phenylazo]-1,2-dihydro-
6-hydroxy-4-methyl-2-oxo-1-
pyridyl}propyl(methyl)am-
monium di(acetate);
3-{5-[4-(3-{1,6-dihydro-2-hy-
droxy-4-methyl-1-[3-
(methylammonio)propyl]-6-
oxo-3-pyridylazo}benzami-
do]phenylazo]-1,2-dihydro-6-
hydroxy-4-methyl-2-oxo-1-
pyridyl}propyl(dimethyl)am-
monium di(acetate);
3-{5-[3-(4-{1-[3-
(dimethylammonio)propyl]-1,6-
dihydro-2-hydroxy-4-methyl-
6-oxo-3-pyridylazo}benzami-
do)phenylazo]-1,2-dihydro-6-
hydroxy-4-methyl-2-oxo-1-
pyridyl}propyl(dimethyl)am-
monium di(acetate)
431-440-5Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
   
607-680-00-3tert-butyl(6-{2-[4-(4-fluoro-
phenyl)-6-isopropyl-2-
[methyl(methylsulfonyl)amino]
pyrimidin-5-yl]vinyl}(4S,6S)-2,2-
dimethyl[1,3]dioxan-4-yl)acetate
432-810-9Aquatic Chronic 4H413H413   
607-681-00-9reaction mass of: 9-nonyl-10-octyl-19-car-
bonyloxyhexadecylnonade-
canoic acid;
9-nonyl-10-octyl-19-
carbonyloxyoctadecylnon-
adecanoic acid;
dihexadecyl 9-nonyl-10-
octylnonadecandioate;
1-octadecyl,19-hexadecyl 9-nonyl-10-octylnonadecan-
dioate;
dioctadecyl 9-nonyl-10-
octylnonadecandioate
432-910-2Aquatic Chronic 4H413H413   
607-682-00-4complex reaction mass of Chinese gum rosin post reacted with acrylic acid434-230-1144413-22-9Aquatic Chronic 4H413H413   
607-683-00-Xreaction mass of: methyl 3-((1E)-2-methylprop-1-enyl)-
2,2-dimethylcyclopropane-
carboxylate;
methyl 3-((1Z)-2-methylprop-1-
enyl)-2,2-dimethylcyclopro-
panecarboxylate (20:80)
435-450-0Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
607-684-00-5alkenes, C12-14, hydroformylation
products, distn. residues,
C-(hydrogen sulfobutanedioates),
disodium salts
435-660-2243662-67-1Skin Irrit. 2
Skin Sens. 1
H315
H317
GHS07
Wng
H315
H317
   
607-685-00-0ammonium
2-cocoyloxyethanesulfonate
441-050-7Skin Irrit. 2
Eye Dam. 1
H315
H318
GHS05
Dgr
H315
H318
   
607-686-00-66,6´-bis(diazo-5,5´,6,6´-tetrahydro-
5,5´-dioxo)[methylene-bis(5-(6-diazo-
5,6-dihydro-5-oxo-1-
naphthylsulphonyloxy)-6-methyl-2-
phenylene]di(naphthalene-1-
sulfonate)
441-550-5Self-react. C ****
Carc. 2
H242
H351
GHS02
GHS08
Dgr
H242
H351
   
607-687-00-1reaction mass of: 2-{3,6-bis-[(2-
ethylphenyl)-methylamino]-
xanthylium-9-yl}-benzene-
sulfonate (2-10 %);
2-{3,6-bis-[(2,3-dimethylphenyl)-
methylamino]-xanthylium-9-yl}-
benzenesulfonate (2-10 %);
2-{3,6-bis-[(2,4-dimethylphenyl)-
methylamino]-xanthylium-9-yl}-
benzenesulfonate (2-10 %);
2-{3,6-bis-[(2,5-dimethylphenyl)-
methylamino]-xanthylium-9-yl}-
benzenesulfonate (2-10 %);
2-{3-[(2,3-dimethylphenyl)-
methylamino]-6-[(2-ethylphenyl)-
methylamino]-xanthylium-9-yl}-
benzenesulfonate (7-20 %);
2-{3-[(2,4-dimethylphenyl)-
methylamino]-6-[(2-ethylphenyl)-
methylamino]-xanthylium-9-yl}-
benzenesulfonate (7-20 %);
2-{3-[(2,5-dimethylphenyl)-
methylamino]-6-[(2-ethylphenyl)-
methylamino]-xanthylium-9-yl}-
benzenesulfonate (7-20 %);
2-{3-[(2,3-dimethylphenyl)-
methylamino]-6-[(2,4-
dimethylphenyl)-methylamino]-
xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,3-dimethylphenyl)-
methylamino]-6-[(2,5-
dimethylphenyl)-methylamino]-
xanthylium-9-yl}-benzene-
sulfonate (7-20 %);
2-{3-[(2,4-dimethylphenyl)-
methylamino]-6-[(2,5-
dimethylphenyl)-methylamino]-
xanthylium-9-yl}-benzene-
sulfonate (7-20 %)
442-800-6Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
   
607-688-00-7(R)-1-cyclohexa-1,4-dienyl-1-
methoxycarbonyl-
methylammoniumchloride
444-320-2Acute Tox. 4 *H302GHS07
Wng
H302   
607-689-00-2reaction mass of: methyl 1,4-
dimethylcyclohexanecar-
boxylate („para-isomer“ including cis- and trans- isomers);
methyl 1,3-dimethylcyclohexane­carboxylate
(„meta-isomer“ including cis- and trans-isomers)
444-920-4Aquatic Chronic 3H412H412   
607-690-00-8dimethyl[2S,2S´]-6,6,6´6´-
tetramethoxy-2,2´-[N,N´-
bis(trifluoracetyl)-S,S´-bi
(L-homocysteinyl) diimino]dihexanoate
432-860-1255387-46-3Skin Sens. 1H317GHS07
Wng
H317   
607-691-00-3magnesium salts, fatty acids, C16-18 and C18 unsaturated, branched and linear448-690-6Aquatic Chronic 4H413H413   
607-692-00-9zinc salts, fatty acids, C16-18 and C18 unsaturated, branched and linear446-470-4Aquatic Chronic 4H413H413   
607-693-00-4hexyl 2-(1-(diethylamino-
hydroxyphenyl)
methanoyl)benzoate
443-860-6302776-68-7Aquatic Chronic 4H413H413   
607-694-00-Xethyl 5,5-diphenyl-2-
isoxazoline-3-carboxylate
443-870-0163520-33-0Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
   
607-696-00-0pentyl formate211-340-6638-49-3Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
H226
H319
H335
GHS02
GHS07
Dgr
H226
H319
H335
  C